These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12840678)

  • 61. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
    Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
    Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Broomé U; Löfberg R; Lundqvist K; Veress B
    Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
    Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
    Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Imam MH; Thackeray EW; Lindor KD
    Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
    Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
    Lynch KD; Chapman RW; Keshav S; Montano-Loza AJ; Mason AL; Kremer AE; Vetter M; de Krijger M; Ponsioen CY; Trivedi P; Hirschfield G; Schramm C; Liu CH; Bowlus CL; Estes DJ; Pratt D; Hedin C; Bergquist A; de Vries AC; van der Woude CJ; Yu L; Assis DN; Boyer J; Ytting H; Hallibasic E; Trauner M; Marschall HU; Daretti LM; Marzioni M; Yimam KK; Perin N; Floreani A; Beretta-Piccoli BT; Rogers JK; ; Levy C
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):179-187.e6. PubMed ID: 31100458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.
    Carbone M; Della Penna A; Mazzarelli C; De Martin E; Villard C; Bergquist A; Line PD; Neuberger JM; Al-Shakhshir S; Trivedi PJ; Baumann U; Cristoferi L; Hov J; Fischler B; Hadzic NH; Debray D; D'Antiga L; Selzner N; Belli LS; Nadalin S
    Transpl Int; 2023; 36():11729. PubMed ID: 37841645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.
    Okada H; Mizuno M; Yamamoto K; Tsuji T
    Acta Med Okayama; 1996 Oct; 50(5):227-35. PubMed ID: 8914675
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical course and management of inflammatory bowel disease after liver transplantation.
    Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
    Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease.
    Yanai H; Matalon S; Rosenblatt A; Awadie H; Berdichevski T; Snir Y; Kopylov U; Katz L; Stein A; Mlynarsky L; Tulchinsky H; Konikoff FM; Horin SB; Braun M; Ben-Ari Z; Chowers Y; Baruch Y; Shibolet O; Dotan I
    J Crohns Colitis; 2015 Feb; 9(2):177-84. PubMed ID: 25518055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.
    Schaeffer DF; Win LL; Hafezi-Bakhtiari S; Cino M; Hirschfield GM; El-Zimaity H
    Dig Dis Sci; 2013 Sep; 58(9):2608-14. PubMed ID: 23670229
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Angulo P; Enders FB; Lindor KD
    Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study.
    Fevery J; Henckaerts L; Van Oirbeek R; Vermeire S; Rutgeerts P; Nevens F; Van Steenbergen W
    Liver Int; 2012 Feb; 32(2):214-22. PubMed ID: 21745316
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc.
    Faubion WA; Loftus EV; Sandborn WJ; Freese DK; Perrault J
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):296-300. PubMed ID: 11593125
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The IBD and PSC Phenotypes of PSC-IBD.
    Ricciuto A; Kamath BM; Griffiths AM
    Curr Gastroenterol Rep; 2018 Mar; 20(4):16. PubMed ID: 29594739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.
    Caron B; Peyrin-Biroulet L; Pariente B; Bouhnik Y; Seksik P; Bouguen G; Caillo L; Laharie D; Carbonnel F; Altwegg R; Reenaers C; Serrero M; Trang-Poisson C; Nancey S; Filippi J; Abitbol V; Savoye G; Vuitton L; Viennot S; Fumery M; Reymond M; Bronowicki JP; Reimund JM; Amiot A
    J Crohns Colitis; 2019 Sep; 13(10):1239-1247. PubMed ID: 31056693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.